|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,160.00 VND | -4.00% |
|
0.00% | -19.21% |
| 08/06 | SPM Corporation Provides Earnings Guidance for the Year 2026 | CI |
| 20/04 | SPM Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 112B 4.27M 3.71M 3.48M 3.26M 6.07M 404M 6.18M 41.57M 16.07M 198M 16.07M 15.62M 690M | P/E 2024 |
33.4x | P/E 2025 | -82x |
|---|---|---|---|---|---|
| Enterprise Value | 182B 6.91M 6M 5.63M 5.27M 9.81M 653M 9.99M 67.24M 25.99M 321M 25.99M 25.26M 1.12B | EV / Sales 2024 |
0.9x | EV / Sales 2025 | 0.82x |
| Free-Float |
17.73% | Yield 2024 |
4.46% | Yield 2025 | - |
| 1 day | -4.00% | ||
| Current month | -13.19% | ||
| 1 month | -8.83% | ||
| 3 months | -7.27% | ||
| 6 months | -16.73% | ||
| Current year | -19.21% |
| 1 month | 8,100 |  | 9,400 |
| Current year | 8,100 | | 10,400 |
| 1 year | 8,100 | | 11,700 |
| 3 years | 8,100 | | 15,100 |
| 5 years | 8,100 | | 34,500 |
| 10 years | 8,100 | | 34,500 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ky The Nguyen
CEO | Chief Executive Officer | 82 | 30/06/2010 |
Chien Tat Van
PRN | Corporate Officer/Principal | 60 | - |
Nhan Thanh Vo
AUD | Comptroller/Controller/Auditor | - | 01/06/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Ky The Nguyen
BRD | Director/Board Member | 82 | 01/01/1990 |
Hoang Huu Dao
CHM | Chairman | 63 | 30/06/2010 |
Khoi Huu Dao
BRD | Director/Board Member | 52 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.00% | 0.00% | -25.82% | -41.71% | 4.28M | |
| +0.92% | -0.47% | +44.98% | +143.50% | 987B | |
| +0.80% | +2.47% | +59.27% | +45.64% | 576B | |
| +0.06% | +5.58% | +27.82% | +72.81% | 415B | |
| +0.25% | -1.30% | +22.76% | +15.66% | 320B | |
| +2.35% | +4.71% | +33.49% | +21.78% | 278B | |
| +0.75% | +3.88% | +30.77% | +37.10% | 279B | |
| +1.23% | +11.15% | -30.87% | -42.75% | 208B | |
| +1.27% | +1.03% | +28.99% | +54.74% | 187B | |
| +0.09% | -1.63% | +17.86% | +61.56% | 155B | |
| Average | -0.05% | +0.04% | +20.93% | +36.83% | 340.52B | |
| Weighted average by Cap. | -0.04% | +0.73% | +34.37% | +67.69% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 298B 11.32M 9.83M 9.23M 8.64M 16.08M 1.07B 16.38M 110M 42.58M 526M 42.58M 41.39M 1.83B | 254B 9.65M 8.38M 7.87M 7.36M 13.71M 913M 13.97M 93.96M 36.32M 448M 36.32M 35.3M 1.56B |
| Net income | 4.62B 175K 152K 143K 134K 249K 16.6M 254K 1.71M 660K 8.16M 660K 642K 28.37M | -1.7B -64.47K -55.99K -52.6K -49.2K -91.62K -6.1M -93.32K -628K -243K -3M -243K -236K -10.42M |
| Net Debt | 112B 4.27M 3.71M 3.49M 3.26M 6.07M 404M 6.19M 41.62M 16.09M 199M 16.09M 15.64M 691M | 69.36B 2.64M 2.29M 2.15M 2.01M 3.75M 249M 3.81M 25.66M 9.92M 122M 9.92M 9.64M 426M |
Employees
250
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- SPM Stock
Select your edition
All financial news and data tailored to specific country editions
